Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Stability of Minoxidil in Espumil Foam Base

Author(s):  Geiger Christine M, Sorenson Bridget, Whaley Paul A

Issue:  Mar/Apr 2013 - Volume 17, Number 2
View All Articles in Issue

Page(s):  165-167

Stability of Minoxidil in Espumil Foam Base Page 1
Stability of Minoxidil in Espumil Foam Base Page 2
Stability of Minoxidil in Espumil Foam Base Page 3

Download in electronic PDF format for $65

Abstract:  Minoxidil is a drug used to stimulate hair growth and to slow balding. It is marketed under a number of trade names, including Rogaine, and is available in varying strength dose forms from a number of generic manufacturers. Minoxidil is available in oral and topical forms. In topical form, it can be applied by a metered-spray or a rub-on applicator. A hydroalcoholic compounding vehicle can minimize greasiness, itching, burning, and contact dermatitis where low concentrations of ethanol and propylene glycol are present. Espumil Foam base contains low concentrations of these ingredients and also can form a foam on topical application. Espumil’s unique delivery by foam-activating packaging assures simple application to difficult-to-treat areas, and it vanishes quickly after application, keeping it in place and avoiding healthy skin areas. The objective of this study was to determine the stability of minoxidil in Espumil Foam base. The studied sample was compounded into a 50-mg/ml solution and stored in a plastic foam- activating bottle at room temperature conditions. Three samples were assayed at each time point out to 90 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced-degradation studies. The beyond-use date is at least 90 days, based on data collected when this formulation was stored at room temperature, protected from light.

Related Keywords: Christine M. Geiger, BS, Bridget Sorenson, BS, CAPM, Paul A. Whaley, BS, minoxidil, hair growth, baldness, excipients, stability

Related Categories: DERMATOLOGY, EXCIPIENTS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Minoxidil in Espumil Foam Base
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Mar/Apr 2013
Pg. 165-167

Stability of Captopril in SyrSPend SF
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013
Pg. 336-338

Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013
Pg. 344-346

Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M
, Sorenson Bridget, Whaley Paul
Sep/Oct 2015
Pg. 420-427

Stability of Rifampin in SyrSpend SF
Sorenson Bridget
, Whaley Paul
Mar/Apr 2013
Pg. 162-164

Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà
, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022
Pg. 330-335

Stability of Ursodiol in SyrSpend SF Cherry Flavored
Geiger Christine M
, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012
Pg. 510-512

Stability of Propranolol Hydrochloride in SyrSpend SF
Geiger Christine M
, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012
Pg. 513-515

Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Whaley Paul A
, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2012
Pg. 164-166

Stability of Gabapentin in SyrSpend SF
Sorenson Bridget
, Voudrie Mark A II, Gehrig Dan
Jul/Aug 2012
Pg. 347-349

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions